Failed Thrombus Aspiration and Decreased Myocardial Perfusion in Patients with STEMI and High Thrombus Load

Half of the patients undergoing percutaneous transluminal coronary angioplasty (PTCA) in a setting of ST-segment elevation acute myocardial infarction (STEMI) experience inadequate myocardial perfusion, known as the no-reflow phenomenon, which contributes to cardiac remodeling and increases mortality. For this reason, effective thrombus removal could reduce the incidence of no-reflow and improve clinical outcomes.

However, studies such as TASTE (Thrombus Aspiration in ST-Elevation Myocardial Infarction in Scandinavia) and TOTAL (Trial of Routine Aspiration Thrombectomy with PCI versus PCI Alone in Patients with STEMI) showed no significant clinical benefits derived from the use of thrombus aspiration (TA). Consequently, its routine application is not recommended. Despite this, many operators continue to perform TA in STEMI patients with a high thrombus load.

The objective of this subanalysis of the Gangwon PCI Registry, a prospective, multicenter, observational registry, was to investigate the effect of failed TA on myocardial perfusion and clinical outcomes in STEMI patients with a high thrombus load who underwent PTCA. Additionally, researchers assessed clinical and angiographic predictors associated with TA failure.

The primary endpoint (PE) was the final TIMI angiographic flow after PTCA. The secondary endpoint (SE) included the final myocardial blush grade, electrocardiographic ST-segment resolution, microvascular obstruction, infarct size (measured by cardiac magnetic resonance imaging), all-cause mortality, cardiovascular mortality, stent thrombosis, and treated-vessel revascularization at one month.

The study included a total of 812 STEMI patients with a high thrombus load who underwent PTCA. Of these, 279 had failed TA and 533 had successful TA. Patients with failed TA were older, but there were no significant differences between the groups in terms of gender, risk factors, or time since the onset of infarction.

Read also: Asymmetry in the Implantation of Self-Expanding Valves in TAVR: Evolution at 5 Years.

The proportion of final TIMI flow grade 3 was lower in the failed TA group compared to the successful TA group (74.6% vs. 82.2%; P = 0.011). Similarly, the failed TA group showed lower myocardial perfusion (reduced blush grade), less electrocardiographic ST-segment resolution, and a higher incidence of microvascular obstruction. TA failure was independently associated with lower final TIMI flow (hazard ratio: 1.525; 95% confidence interval [CI]: 1.048-2.218; P = 0.027).

Factors associated with TA failure included older age, Killip class ≥III, vessel tortuosity, calcification, and a culprit vessel other than the left anterior descending artery.

Conclusion

Failed TA was associated with reduced myocardial perfusion in STEMI patients with a high thrombus load who underwent primary PTCA. Older age, hemodynamic instability, tortuosity and calcification of the infarct-related artery, and involvement of arteries other than the left anterior descending artery reduce the effectiveness of thrombus aspiration in a setting of STEMI.

Original Title: Failed Thrombus Aspiration and Reduced Myocardial Perfusion in Patients With STEMI and Large Thrombus Burden.

Reference: Ho Sung Jeon, MD et al JACC Cardiovasc Interv. 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...